1 Department of Pharmaceutical and Environmental Health Sciences, College of Pharmacy and Health Sciences, Texas Southern University , Houston, Texas.
2 Department of Basic Medical Sciences, Pharmacology Section, University of the West Indies , Kingston, Jamaica .
J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):134-140. doi: 10.1089/jop.2017.0124. Epub 2018 Jan 25.
To determine the serotonergic (5HT) receptor subtype mediating the contraction of bovine posterior ciliary arteries (BPCAs) in vitro.
Longitudinal isometric tension was measured in BPCA strips (4-5 mm) mounted in 25 mL organ baths containing oxygenated Krebs solution at 37°C. Cumulative contractile concentration-response (C-R) curves were generated for various 5-HT agonists to assess their potencies and maximal degrees of contraction. Multiple agonist C-R curves were also constructed in the presence and absence of receptor-selective antagonists to determine antagonist potencies using Schild plots.
Selective and nonselective agonists for 5-HT receptors elicited concentration-dependent contractile responses in BPCAs with the following rank order of potency: MK-212 > BW723C86 > α-methyl-5-HT >5-methoxy-α-5-methyl-5-HT >> R-DO1 > >5-HT >> cabergoline >> 5-methoxy-dimethyl-tryptamine >> 2-methyl-5-HT >> tryptamine. Interestingly, both 8-OH-DPAT (5HT agonist) and quipazine (5HT agonist) did not elicit contractions in BPCAs. The contractions produced by BW723C86 (5-HT agonist) were antagonized by 5-HT receptor blockers, RS-127445 (5-HT antagonist), and M-100907 (5-HT antagonist), yielding antagonist pA values of 7.5 ± 0.12 (n = 4) and 6.2 ± 0.17 (n = 4), respectively. Furthermore, contractions elicited by MK-212 (5-HT agonist) was blocked by RS-102221 (5-HT antagonist), although noncompetitively.
On the basis of the pharmacological profile of selective agonists and antagonists, we conclude that serotonin-induced contractions of the BPCA are mediated primarily by a combination of 5HT and/or 5HT receptors. It appears that 5-HT and 5-HT receptors are not involved in the contractile action of BPCAs to serotonin.
确定介导体外牛后睫状动脉(BPCA)收缩的 5-羟色胺能(5HT)受体亚型。
在含有氧合 Krebs 溶液的 37°C 25ml 器官浴中,测量 BPCA 条带(4-5mm)的纵向等长张力。为各种 5-HT 激动剂生成累积收缩浓度-反应(C-R)曲线,以评估其效力和最大收缩程度。还在存在和不存在受体选择性拮抗剂的情况下构建多激动剂 C-R 曲线,以使用 Schild 图确定拮抗剂效力。
5-HT 受体的选择性和非选择性激动剂在 BPCA 中引起浓度依赖性收缩反应,效力的顺序如下:MK-212> BW723C86>α-甲基-5-HT>5-甲氧基-α-5-甲基-5-HT>>R-DO1>>5-HT>>卡麦角林>>5-甲氧基-二甲基-色胺>>2-甲基-5-HT>>色胺。有趣的是,8-OH-DPAT(5-HT 激动剂)和 quipazine(5-HT 激动剂)都没有引起 BPCA 的收缩。BW723C86(5-HT 激动剂)引起的收缩被 5-HT 受体阻滞剂 RS-127445(5-HT 拮抗剂)和 M-100907(5-HT 拮抗剂)拮抗,产生的拮抗剂 pA 值分别为 7.5±0.12(n=4)和 6.2±0.17(n=4)。此外,MK-212(5-HT 激动剂)引起的收缩被 RS-102221(5-HT 拮抗剂)非竞争性阻断。
根据选择性激动剂和拮抗剂的药理学特征,我们得出结论,5-羟色胺诱导的 BPCA 收缩主要由 5HT 和/或 5HT 受体介导。5-HT 和 5-HT 受体似乎不参与 5-HT 对 BPCA 的收缩作用。